Binder profile
ZINC44675971
Virtual-screening candidate from ZINC.
Bound to: PA5514 — beta-lactamase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC44675971- UniProt (similar protein)
Q9L4P2- Tanimoto
- 0.530
- Target protein
- PA5514
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 383.5
- LogP ≤ 5 -0.31
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 110.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@@H](O)[C@@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@@H]12C[C@@H](O)[C@@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@@H]12
InChI=1S/C17H25N3O5S/c1-7-12-11(8(2)21)16(23)20(12)13(17(24)25)14(7)26-9-5-10(18-6-9)15(22)19(3)4/h7-12,18,21H,5-6H2,1-4H3,(H,24,25)/t7-,8-,9+,10+,11+,12+/m1/s1InChI=1S/C17H25N3O5S/c1-7-12-11(8(2)21)16(23)20(12)13(17(24)25)14(7)26-9-5-10(18-6-9)15(22)19(3)4/h7-12,18,21H,5-6H2,1-4H3,(H,24,25)/t7-,8-,9+,10+,11+,12+/m1/s1
DMJNNHOOLUXYBV-HAVMIZHYSA-NDMJNNHOOLUXYBV-HAVMIZHYSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- KE1
- Homolog
- Q9L4P2
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC44675971 →
- ZINC ZINC20 ZINC44675971 →
- UniProt UniProt Q9L4P2 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC44675971”) →
Other binders for this protein
Quick navigation to other ligands bound to PA5514.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 48
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).